Follow
Andreas Kateifides, MD, PhD
Andreas Kateifides, MD, PhD
Alexion Pharmaceuticals
Verified email at bu.edu
Title
Cited by
Cited by
Year
ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCAT [S]
A Duka, P Fotakis, D Georgiadou, A Kateifides, K Tzavlaki, ...
Journal of lipid research 54 (1), 107-115, 2013
472013
Apolipoprotein AI exerts bactericidal activity against Yersinia enterocolitica serotype O: 3
M Biedzka-Sarek, J Metso, A Kateifides, T Meri, TS Jokiranta, A Muszyński, ...
Journal of Biological Chemistry 286 (44), 38211-38219, 2011
472011
Mutation in APOA1 predicts increased risk of ischaemic heart disease and total mortality without low HDL cholesterol levels
CL Haase, R Frikke‐Schmidt, BG Nordestgaard, AK Kateifides, ...
Journal of internal medicine 270 (2), 136-146, 2011
472011
Carboxyl terminus of apolipoprotein AI (ApoA-I) is necessary for the transport of lipid-free ApoA-I but not prelipidated ApoA-I particles through aortic endothelial cells
PM Ohnsorg, L Rohrer, D Perisa, A Kateifides, A Chroni, D Kardassis, ...
Journal of biological chemistry 286 (10), 7744-7754, 2011
362011
Role of the hydrophobic and charged residues in the 218–226 region of apoA-I in the biogenesis of HDL1 [S]
P Fotakis, AK Kateifides, C Gkolfinopoulou, D Georgiadou, M Beck, ...
Journal of lipid research 54 (12), 3281-3292, 2013
172013
Comparative effects of ertapenem, imipenem, and meropenem on the colonization of the gastrointestinal tract of mice by Candida albicans
G Samonis, S Maraki, K Leventakos, AM Spanaki, A Kateifidis, ...
Medical mycology 44 (3), 233-235, 2006
172006
Significance of the hydrophobic residues 225–230 of apoA-I for the biogenesis of HDL1 [S]
P Fotakis, I Tiniakou, AK Kateifides, C Gkolfinopoulou, A Chroni, ...
Journal of lipid research 54 (12), 3293-3302, 2013
162013
Alteration of negatively charged residues in the 89 to 99 domain of apoA-I affects lipid homeostasis and maturation of HDL [S]
AK Kateifides, IN Gorshkova, A Duka, A Chroni, D Kardassis, VI Zannis
Journal of Lipid Research 52 (7), 1363-1372, 2011
142011
Pleiotropic functions of HDL lead to protection from atherosclerosis and other diseases
V Zannis, A Kateifides, P Fotakis, E Zanni, D Kardassis
Dyslipidemia-From Prevention to Treatment, 173-96, 2012
122012
WCN23-0140 A PHASE 2 STUDY EVALUATING THE EFFICACY AND SAFETY OF RAVULIZUMAB IN PATIENTS WITH IMMUNOGLOBULIN A (IgA) NEPHROPATHY OR PROLIFERATIVE LUPUS NEPHRITIS (LN)
A Kateifides, K Garlo, K Rice, N Spoerri, N Najafian
Kidney International Reports 8 (3), S54-S55, 2023
12023
Mutation in APOA1 predicts increased risk of ischaemic heart disease and mortality without low HDL cholesterol
CL Haase, R Frikke-Schmidt, BG Nordestgaard, AK Kateifides, ...
Amyloid 17, 129, 2010
2010
119 MUTATION IN APOAI PREDICTS INCREASED RISK OF ISCHEMIC HEART DISEASE AND EARLY DEATH WITHOUT LOW HDL CHOLESTEROL
C Lundegaard, R Frikke-Schmidt, B Nordestgaard, A Kateifides, ...
Atherosclerosis (Supplements)(Component) 2 (10), e235, 2009
2009
Resequencing APOAI Identifies Common Mutation that Predicts Increased Risk of Ischemic Heart Disease and Decreased Longevity without Dyslipidemia
C Lundegaard, R Frikke-Schmidt, BG Nordestgaard, AK Kateifides, ...
Circulation 118 (suppl_18), S_955-S_955, 2008
2008
The system can't perform the operation now. Try again later.
Articles 1–13